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intraoperative aortic clamping time were specific predic-
tors for PO mortality in descending significance.
Regression analysis defined high preoperative serum
cTnT and CK-MB and old age the most significant speci-
fic predictors of PO mortality.
Conclusion: Oldage,multiple diseasedvessels and low left
ventricular ejection fraction in conjunction with high
preoperative serum levels of myocardial ischemia bio-
markers could predict PO mortality after CABG surgery.
However, high preoperative troponin levels were signifi-
cantly superior predictor for PO mortality than CK-MB.
http://dx.doi:10.1016/j.jsha.2015.05.258
78. Coronary bypass using bilateral internal
mammary arteries in an achondroplast
Mohamed Abdulwahab Alassal, Mohamed
Salaman Koudeih, Mostafa Adel Youssof
Coronary bypass grafting for ischemic heart disease in
achondroplastic dwarfs is very rare. Shortage of veins and
sometimes, inadequate vein quality can cause difficulties
during surgery. Only two achondroplastic cases were
reported in literature that underwent coronary bypass
surgery, in which the left internal mammary artery and
vein grafts were used. To the best of our knowledge using
bilateral internal mammary arteries in such patients was
not reported. We report here a 55 years old male
achondroplastic dwarf who had triple vessels coronary
disease that underwent successful coronary bypass
surgery using bilateral mammary arteries. Anatomic
and surgical challenges in achondroplasia are highlighted
http://dx.doi:10.1016/j.jsha.2015.05.259
79. Heart transplantation in a patient with eosino-
philic granulomatosis with polyangitis (Churg–
Strauss syndrome)
Tarek Omran, Nedim Selimovic, Atli Eyjolfsson
Background: Churg–Strauss syndrome, recently renamed
eosinophilic granulomatosis with polyangitis (EGPA),
was first described in 1951. It is characterized by blood
and tissue eosinophilia and disseminated necrotizing
vasculitis in asthmatic patients (1).
Heart involvement is the leading cause of death in
most of these patients which occurs in approximately
8–20% of EGPA patients and is more frequent in
ANCA  patients (2).
Case: We report a 32 years old man with Churg–Strauss
syndrome. He presented with a history of bronchial
asthma and corticosteroid treatment. The patient devel-
oped severe heart failure necessitating heart transplanta-
tion in May 2014. His post operative course was
uneventful except for tricuspid regurgitation which sub-
sided during the first two months follow-up.
Up till now, the patient has had 5 endomyocardial
biopsies with no evidence of acute rejection (grade 0) or
recurrence of EGPA.
Conclusion: Only 9 patients with EGPA (Churg–Strauss
syndrome) who received heart transplantation have been
reported in a retrospective international multicentre
study (3).
To our knowledge this is the 10th case of heart trans-
plantation in a patient with EGPA (Churg–Strauss
syndrome).
http://dx.doi:10.1016/j.jsha.2015.05.260
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A. Al Otay, K. Al Najashi, R.M. Di Donato
Department of Pediatric Cardiac Surgery, Prince Sultan
Cardiac Centre, Prince Sultan Medical Military City,
Riyadh, Saudi Arabia
Aim: The choice between primary and staged repair of
atrioventricular septal defect with tetralogy of Fallot
(AVSD/TOF) is still controversial. We report our surgical
experience with this lesion.
Methods: Twenty-four patients with AVSD/TOF were
repairedbetween1997 and2013.Ten,group1 (40%),under-
went primary repair at a mean age of 29.4 months.
Fourteen, group 2 (60%), underwent staged repair at a
mean-age of 65.2 months. Mean interval between shunt
and repairwas26.5 months.Outof 24patients, 8 (33%)were
repaired by transannular patch, 15 (62%) by pulmonary
valve preservation and 1 by pulmonary valve replacement.
Results: There was one hospital death in group 2. Mean
follow-up period was 70 months. In group 1, 8 patients
were alive while 2 were lost to follow-up. Three were
re-operated, one for mitral valve repair and left
diaphragmatic plication, one for thoracic duct ligation
and one for pulmonary valve replacement. In group 2,
10 patients were alive while 3 were lost to follow-up.
One developed biventricular outflow obstruction and is
awaiting surgery. One had ventricular septal defect
device closure. There were 3 reoperations, one for left
atrioventricular valve and pulmonary valve replacement,
one for pulmonary valve replacement alone and one for
relief of biventricular outflow obstruction. All transannu-
lar patch patients had dilated right ventricle with moder-
ate to severe tricuspid valve regurgitation.
Conclusion: Shunt procedure is a reasonable initial
option for many of patients with AVSD/TOF but primary
repair can be performed in selected patients with low
operative mortality and reasonable morbidity.
http://dx.doi:10.1016/j.jsha.2015.05.261
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